Search

everythinglearnresearchcommunity

for

Search:↓

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Certain hair and scalp features can predict the severity of alopecia areata.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Carcinosin, a homeopathic remedy, helped a young girl with alopecia areata regrow hair and reduce psychological symptoms.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Compound glycyrrhizin combined with conventional treatments effectively and safely promotes hair regrowth in alopecia areata patients.

Compound glycyrrhizin with conventional treatments is effective and safe for promoting hair regrowth in alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Oral Apremilast effectively treats alopecia areata in most patients.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.